Skip to content
Wednesday June 12, 2024
12:10 pmInnovation
The reawakening of nuclear medicine
Nuclear medicine has long had its place in the diagnosis and treatment of disease, primarily in cardiology and oncology. Today, the nuclear medicine market is at an inflection point, as the rise of theragnostics and the advent of novel products is expected to nearly quadruple the size of the market in the next 10 years from ~$7bn to $25+bn by 2033. The enormous growth in the field is driven by continued radiopharmaceutical funding where 250+ trials are currently being conducted and by trial funding increasing ~45%+ p.a. between 2019 and 2022. This session features perspectives from a provider, radiopharmaceutical group and OEM on how this is accelerating growth, shaping the market and discussing the medium and long-term obstacles.
Moderation and market overview: Ian Poburenny, Director, Rothschild & Co
Speakers include:
Chait Tatineni, CEO International and Chief M&A Officer, Curium
Nick Burley, Group CEO, Alliance Medical
Ben Newton, Global Head of Oncology, GE Healthcare
Ian PoburennyDirectorRothschild & Co
Chaitanya TatineniCEO International and Chief M&A OfficerCurium
Nick BurleyGroup CEOAlliance Medical
Ben NewtonGlobal Head of OncologyGE HealthCare
Ballroom 1+2
The reawakening of nuclear medicine
Nuclear medicine has long had its place in the diagnosis and treatment of disease, primarily in cardiology and oncology. Today, the nuclear medicine market is at an inflection point, as the rise of theragnostics and the advent of novel products is expected to nearly quadruple the size of the market in the next 10 years from ~$7bn to $25+bn by 2033. The enormous growth in the field is driven by continued radiopharmaceutical funding where 250+ trials are currently being conducted and by trial funding increasing ~45%+ p.a. between 2019 and 2022. This session features perspectives from a provider, radiopharmaceutical group and OEM on how this is accelerating growth, shaping the market and discussing the medium and long-term obstacles.
Moderation and market overview: Ian Poburenny, Director, Rothschild & Co
Speakers include:
Chait Tatineni, CEO International and Chief M&A Officer, Curium
Nick Burley, Group CEO, Alliance Medical
Ben Newton, Global Head of Oncology, GE Healthcare
Ballroom 1+2
Speakers
Ian PoburennyDirectorRothschild & Co
Chaitanya TatineniCEO International and Chief M&A OfficerCurium
Nick BurleyGroup CEOAlliance Medical
Ben NewtonGlobal Head of OncologyGE HealthCare
Explore more sessions
View the agenda and see how this event will accelerate your business goals.
Explore similar sessions
7:45 amInteractive Workshop
Breakfast Briefing: Design thinking – how to make an impact in innovation, transformation and patient experience
Design thinking is deployed to get to the heart of complex issues, a step-by-step approach involving a lot of listening to ensure that ideas aren’t just creative but are effective...
Ballroom 3
Craig WillsManaging DirectorHi Mum! Said Dad
Katya ZubarevaPartnerL.E.K. Consulting
Klaus BoehnckePartnerL.E.K. Consulting
Jacqueline ThompsonPartnerL.E.K. Consulting
Breakfast Briefing: Design thinking – how to make an impact in innovation, transformation and patient experience
Design thinking is deployed to get to the heart of complex issues, a step-by-step approach involving a lot of listening to ensure that ideas aren’t just creative but are effective and practical – ultimately ensuring that they get adopted. For healthcare CxOs, now is the perfect time to deploy the process with the sector adopting technology at breakneck speed ensuring the voices of all stakeholders are heard as new products, services and care delivery models are developed.
Join Craig Wills, CEO of Hi Mum! Said Dad (an L.E.K. company) and L.E.K.’s Katya Zubareva, Klaus Boehncke and Jacqueline Thompson for this breakfast at HBI 2024, sharing case studies into successful projects that followed this approach and demonstrating the concept, based on working with a leading fertility clinic.
Attendees will leave with a better understanding of the process and when and how to deploy design thinking. If you are developing new products and services, looking to enhance patient and clinician experience, solving complex challenges, or looking to drive change this breakfast is a must-attend.
We hope that you can join us for what is sure to be a lively and informative discussion – with complimentary breakfast!
Please register to attend.
Ballroom 3
Speakers
Craig WillsManaging DirectorHi Mum! Said Dad
Katya ZubarevaPartnerL.E.K. Consulting
Klaus BoehnckePartnerL.E.K. Consulting
Jacqueline ThompsonPartnerL.E.K. Consulting
2:00 pmPlenary
Getting the most out of your data
How are providers assessing and extracting value from their data? How do you best analyse it to improve outcomes and patient experience? And how do you best analyse it to...
Ballroom 1+2
Prof Dr Jörg DebatinFounderHonic
Mark StoeszVice President Enterprise Solutions and Partnerships International MarketsGE HealthCare
Bjoern von SiemensCo-Founder and Chief Business OfficerCaresyntax
Barty Pleydell-BouverieSenior Asset Leader, Healthcare Analytics McKinsey & Company
Getting the most out of your data
How are providers assessing and extracting value from their data? How do you best analyse it to improve outcomes and patient experience? And how do you best analyse it to optimise workflow and patient throughput? Three case studies demonstrate what is possible and the pitfalls to avoid.
Speakers include:
Prof Dr Jörg Debatin, Founder, Honic
Mark Stoesz, Vice President Enterprise Solutions & Partnerships International, GE Healthcare
Bjoern van Siemens, Co-Founder and CFO, Caresyntax
Moderated by Barty Pleydell-Bouverie, Senior Asset Leader, Healthcare Analytics, McKinsey & Company
Ballroom 1+2
Speakers
Prof Dr Jörg DebatinFounderHonic
Mark StoeszVice President Enterprise Solutions and Partnerships International MarketsGE HealthCare
Bjoern von SiemensCo-Founder and Chief Business OfficerCaresyntax
Barty Pleydell-BouverieSenior Asset Leader, Healthcare Analytics McKinsey & Company
3:00 pmNew Business Models
Building your patient pipeline: How consumerisation is changing the business model
As demand rises and capacity remains a challenge for the public sector globally, patients are turning to self-pay and private medical insurance. With this patients have shifted to become consumers,...
Ballroom 1+2
Peter CorfieldChief Commercial OfficerSpire Healthcare
Dr Katie TryonDirector of Health StrategyVitality Health
Charlie BullockCo-Founder & CEOScan.com
Tom McMullenManaging DirectorHBI
Building your patient pipeline: How consumerisation is changing the business model
As demand rises and capacity remains a challenge for the public sector globally, patients are turning to self-pay and private medical insurance. With this patients have shifted to become consumers, demanding speed, more control over their care pathway and a return on their own investment; increased quality and outcomes. This session features three CEOs who outline how consumerisation has led to new business models, strong brands and long-term patient engagement including how to best build really sticky apps.
Peter Corfield, Chief Commercial Officer, Spire
Dr Katie Tryon, Director of Health Strategy, Vitality
Charlie Bullock, CEO, Scan.com
Moderated by Tom McMullen, Managing Director, Healthcare Business International
Ballroom 1+2
Speakers
Peter CorfieldChief Commercial OfficerSpire Healthcare
Dr Katie TryonDirector of Health StrategyVitality Health
Charlie BullockCo-Founder & CEOScan.com
Tom McMullenManaging DirectorHBI
